histrelin: Clinical Trials

7 trials of histrelin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting, 3 completed, 1 recruiting. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Active not recruiting 3, Completed 3, Recruiting 1
Phase 21Active not recruiting 1

Follow histrelin: new trials by email Literature Review of histrelin trials Research Report on histrelin

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
Bicalutamide, Buserelin, Darolutamide - Prostate Adenocarcinoma
Phase 3Active not recruitingNRG Oncology20502021-12-062026-08-17
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
PET-directed Local Therapy using Surgery, PET-directed Local Therapy using Radiation, Salvage Local Therapy for locally recurrent disease - Prostate Cancer, Oligometastasis
Phase 2 / Phase 3Active not recruitingVA Office of Research and Development3782021-07-012026-11-05
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
Apalutamide, Bicalutamide, Biospecimen Collection - Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3Active not recruitingNRG Oncology27532021-01-212026-08-17
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Abiraterone, Bicalutamide, Degarelix - Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3RecruitingSWOG Cancer Research Network12732018-09-242026-10-08
Histrelin Subcutaneous Implant in Children With Central Precocious Puberty
Histrelin Subcutaneous Implant - Central Precocious Puberty
Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company362004-09-012021-01-08
Study of Histrelin Subdermal Implant in Patients With Prostate Cancer
Histrelin hydrogel implant, Zoladex goserelin implant - Prostate Cancer, Adenocarcinoma of the Prostate
Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company592000-05-012024-01-02
Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer
histrelin acetate - Prostate Cancer, Adenocarcinoma of the Prostate
Phase 3CompletedEndo USA Inc., a Keenova Therapeutics Company1382000-04-012024-01-02

Conditions studied

Prostatic Neoplasms (5)  ·  Neoplasm Metastasis (1)  ·  Puberty, Precocious (1)  ·  Salivary Gland Adenoma, Pleomorphic (1)

Sponsors

Endo USA Inc., a Keenova Therapeutics Company (3)  ·  NRG Oncology (2)  ·  SWOG Cancer Research Network (1)  ·  VA Office of Research and Development (1)

Countries

United States (4)  ·  Canada (2)  ·  Chile (1)  ·  Colombia (1)  ·  Mexico (1)  ·  Switzerland (1)

Top investigators

Abhishek Solanki, MD MS (1)  ·  Brian Chapin (1)  ·  Erica A Eugster, MD (1)  ·  Neil B Desai (1)  ·  Paul L Nguyen (1)  ·  Regulatory Division (1)

Results publications

PMID 16515997, PMID 24295437, PMID 25803268

NIH funding

U10CA180868 (2), I01CX002277 (1), U10CA180888 (1)